These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
174 related articles for article (PubMed ID: 30272291)
1. Emodin suppresses angiogenesis and metastasis in anaplastic thyroid cancer by affecting TRAF6‑mediated pathways in vivo and in vitro. Shi GH; Zhou L Mol Med Rep; 2018 Dec; 18(6):5191-5197. PubMed ID: 30272291 [TBL] [Abstract][Full Text] [Related]
2. Magnolol suppresses hypoxia-induced angiogenesis via inhibition of HIF-1α/VEGF signaling pathway in human bladder cancer cells. Chen MC; Lee CF; Huang WH; Chou TC Biochem Pharmacol; 2013 May; 85(9):1278-87. PubMed ID: 23416116 [TBL] [Abstract][Full Text] [Related]
3. Antitumor activity of Pulsatilla koreana extract in anaplastic thyroid cancer via apoptosis and anti-angiogenesis. Park BH; Jung KH; Son MK; Seo JH; Lee HS; Lee JH; Hong SS Mol Med Rep; 2013 Jan; 7(1):26-30. PubMed ID: 23135100 [TBL] [Abstract][Full Text] [Related]
4. Imperatorin suppresses proliferation and angiogenesis of human colon cancer cell by targeting HIF-1α via the mTOR/p70S6K/4E-BP1 and MAPK pathways. Mi C; Ma J; Wang KS; Zuo HX; Wang Z; Li MY; Piao LX; Xu GH; Li X; Quan ZS; Jin X J Ethnopharmacol; 2017 May; 203():27-38. PubMed ID: 28341244 [TBL] [Abstract][Full Text] [Related]
5. Aplidin reduces growth of anaplastic thyroid cancer xenografts and the expression of several angiogenic genes. Straight AM; Oakley K; Moores R; Bauer AJ; Patel A; Tuttle RM; Jimeno J; Francis GL Cancer Chemother Pharmacol; 2006 Jan; 57(1):7-14. PubMed ID: 16001179 [TBL] [Abstract][Full Text] [Related]
6. Jianpi Jiedu decoction, a traditional Chinese medicine formula, inhibits tumorigenesis, metastasis, and angiogenesis through the mTOR/HIF-1α/VEGF pathway. Peng W; Zhang S; Zhang Z; Xu P; Mao D; Huang S; Chen B; Zhang C; Zhang S J Ethnopharmacol; 2018 Oct; 224():140-148. PubMed ID: 29852266 [TBL] [Abstract][Full Text] [Related]
7. Apatinib Inhibits Angiogenesis Via Suppressing Akt/GSK3β/ANG Signaling Pathway in Anaplastic Thyroid Cancer. Jin Z; Cheng X; Feng H; Kuang J; Yang W; Peng C; Shen B; Qiu W Cell Physiol Biochem; 2017; 44(4):1471-1484. PubMed ID: 29190616 [TBL] [Abstract][Full Text] [Related]
8. Dual inhibition of plasminogen kringle 5 on angiogenesis and chemotaxis suppresses tumor metastasis by targeting HIF-1α pathway. Cai WB; Zhang Y; Cheng R; Wang Z; Fang SH; Xu ZM; Yang X; Yang ZH; Ma JX; Shao CK; Gao GQ PLoS One; 2012; 7(12):e53152. PubMed ID: 23300882 [TBL] [Abstract][Full Text] [Related]
9. Centchroman regulates breast cancer angiogenesis via inhibition of HIF-1α/VEGFR2 signalling axis. Dewangan J; Kaushik S; Rath SK; Balapure AK Life Sci; 2018 Jan; 193():9-19. PubMed ID: 29196053 [TBL] [Abstract][Full Text] [Related]
10. Rhaponticin decreases the metastatic and angiogenic abilities of cancer cells via suppression of the HIF‑1α pathway. Kim A; Ma JY Int J Oncol; 2018 Sep; 53(3):1160-1170. PubMed ID: 30015877 [TBL] [Abstract][Full Text] [Related]
11. Low-Level Laser Therapy Promoted Aggressive Proliferation and Angiogenesis Through Decreasing of Transforming Growth Factor-β1 and Increasing of Akt/Hypoxia Inducible Factor-1α in Anaplastic Thyroid Cancer. Rhee YH; Moon JH; Choi SH; Ahn JC Photomed Laser Surg; 2016 Jun; 34(6):229-35. PubMed ID: 27078192 [TBL] [Abstract][Full Text] [Related]
12. Distribution and Activity of Lenvatinib in Brain Tumor Models of Human Anaplastic Thyroid Cancer Cells in Severe Combined Immune Deficient Mice. Wang R; Yamada T; Arai S; Fukuda K; Taniguchi H; Tanimoto A; Nishiyama A; Takeuchi S; Yamashita K; Ohtsubo K; Matsui J; Onoda N; Hirata E; Taira S; Yano S Mol Cancer Ther; 2019 May; 18(5):947-956. PubMed ID: 30926637 [TBL] [Abstract][Full Text] [Related]
13. Role of Krüppel-Like Factor 4 in the Maintenance of Chemoresistance of Anaplastic Thyroid Cancer. Lee SI; Kim DK; Seo EJ; Choi EJ; Kwon YW; Jang IH; Lee JC; Kim HY; Shong M; Kim JH; Kim SJ Thyroid; 2017 Nov; 27(11):1424-1432. PubMed ID: 28920531 [TBL] [Abstract][Full Text] [Related]
14. Inhibition of TRAF6 alleviates choroidal neovascularization in vivo. Ding D; Zhu M; Liu X; Jiang L; Xu J; Chen L; Liang J; Li L; Zhou T; Wang Y; Shi H; Yuan Y; Song E Biochem Biophys Res Commun; 2018 Sep; 503(4):2742-2748. PubMed ID: 30103950 [TBL] [Abstract][Full Text] [Related]
15. Emodin inhibits angiogenesis in pancreatic cancer by regulating the transforming growth factor-β/drosophila mothers against decapentaplegic pathway and angiogenesis-associated microRNAs. Lin SZ; Xu JB; Ji X; Chen H; Xu HT; Hu P; Chen L; Guo JQ; Chen MY; Lu D; Wang ZH; Tong HF Mol Med Rep; 2015 Oct; 12(4):5865-71. PubMed ID: 26238071 [TBL] [Abstract][Full Text] [Related]
16. Emodin inhibits epithelial‑mesenchymal transition and metastasis of triple negative breast cancer via antagonism of CC‑chemokine ligand 5 secreted from adipocytes. Song X; Zhou X; Qin Y; Yang J; Wang Y; Sun Z; Yu K; Zhang S; Liu S Int J Mol Med; 2018 Jul; 42(1):579-588. PubMed ID: 29693154 [TBL] [Abstract][Full Text] [Related]
17. Interleukin-11 promotes epithelial-mesenchymal transition in anaplastic thyroid carcinoma cells through PI3K/Akt/GSK3β signaling pathway activation. Zhong Z; Hu Z; Jiang Y; Sun R; Chen X; Chu H; Zeng M; Sun C Oncotarget; 2016 Sep; 7(37):59652-59663. PubMed ID: 27487122 [TBL] [Abstract][Full Text] [Related]
18. Tanshinone IIA inhibits β-catenin/VEGF-mediated angiogenesis by targeting TGF-β1 in normoxic and HIF-1α in hypoxic microenvironments in human colorectal cancer. Sui H; Zhao J; Zhou L; Wen H; Deng W; Li C; Ji Q; Liu X; Feng Y; Chai N; Zhang Q; Cai J; Li Q Cancer Lett; 2017 Sep; 403():86-97. PubMed ID: 28602978 [TBL] [Abstract][Full Text] [Related]
19. Piceatannol-3-O-β-D-glucopyranoside (PG) exhibits in vitro anti-metastatic and anti-angiogenic activities in HT1080 malignant fibrosarcoma cells. Kim A; Ma JY Phytomedicine; 2019 Apr; 57():95-104. PubMed ID: 30668328 [TBL] [Abstract][Full Text] [Related]
20. CLM94, a novel cyclic amide with anti-VEGFR-2 and antiangiogenic properties, is active against primary anaplastic thyroid cancer in vitro and in vivo. Antonelli A; Bocci G; La Motta C; Ferrari SM; Fallahi P; Ruffilli I; Di Domenicantonio A; Fioravanti A; Sartini S; Minuto M; Piaggi S; Corti A; Alì G; Di Desidero T; Berti P; Fontanini G; Danesi R; Da Settimo F; Miccoli P J Clin Endocrinol Metab; 2012 Apr; 97(4):E528-36. PubMed ID: 22278419 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]